MONTREAL--(BUSINESS WIRE)--Angiochem, Inc. a clinical-stage biotechnology company developing drugs that are uniquely capable of crossing the blood-brain barrier to treat brain diseases, announced today that Queenie Jang, Angiochem’s VP of Corporate Development, will present at the Cowen and Company 30th Annual Health Care Conference on Wednesday, March 10, 2010, at 2:30p.m. EST in the MIT room, 3rd floor at the Boston Marriott Copley Place in Boston, Massachusetts.
